247 related articles for article (PubMed ID: 30442969)
21. Commensal Microbiota Promote Lung Cancer Development via γδ T Cells.
Jin C; Lagoudas GK; Zhao C; Bullman S; Bhutkar A; Hu B; Ameh S; Sandel D; Liang XS; Mazzilli S; Whary MT; Meyerson M; Germain R; Blainey PC; Fox JG; Jacks T
Cell; 2019 Feb; 176(5):998-1013.e16. PubMed ID: 30712876
[TBL] [Abstract][Full Text] [Related]
22. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data.
Davis NM; Proctor DM; Holmes SP; Relman DA; Callahan BJ
Microbiome; 2018 Dec; 6(1):226. PubMed ID: 30558668
[TBL] [Abstract][Full Text] [Related]
23. Contamination in Low Microbial Biomass Microbiome Studies: Issues and Recommendations.
Eisenhofer R; Minich JJ; Marotz C; Cooper A; Knight R; Weyrich LS
Trends Microbiol; 2019 Feb; 27(2):105-117. PubMed ID: 30497919
[TBL] [Abstract][Full Text] [Related]
24. The human microbiome and cancer: a diagnostic and therapeutic perspective.
Kandalai S; Li H; Zhang N; Peng H; Zheng Q
Cancer Biol Ther; 2023 Dec; 24(1):2240084. PubMed ID: 37498047
[TBL] [Abstract][Full Text] [Related]
25. Intratumoural microbiome can predict the prognosis of hepatocellular carcinoma after surgery.
Sun L; Ke X; Guan A; Jin B; Qu J; Wang Y; Xu X; Li C; Sun H; Xu H; Xu G; Sang X; Feng Y; Sun Y; Yang H; Mao Y
Clin Transl Med; 2023 Jul; 13(7):e1331. PubMed ID: 37462602
[TBL] [Abstract][Full Text] [Related]
26. Immuno-oncology-microbiome axis of gastrointestinal malignancy.
Lin Q; Guan SW; Yu HB
World J Gastrointest Oncol; 2023 May; 15(5):757-775. PubMed ID: 37275452
[TBL] [Abstract][Full Text] [Related]
27. Integrating bulk and single-cell RNA sequencing data reveals the relationship between intratumor microbiome signature and host metabolic heterogeneity in breast cancer.
Chen F; Yang J; Guo Y; Su D; Sheng Y; Wu Y
Front Immunol; 2023; 14():1140995. PubMed ID: 36999009
[TBL] [Abstract][Full Text] [Related]
28. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer.
Galeano Niño JL; Wu H; LaCourse KD; Kempchinsky AG; Baryiames A; Barber B; Futran N; Houlton J; Sather C; Sicinska E; Taylor A; Minot SS; Johnston CD; Bullman S
Nature; 2022 Nov; 611(7937):810-817. PubMed ID: 36385528
[TBL] [Abstract][Full Text] [Related]
29. The composition of lung microbiome in lung cancer: a systematic review and meta-analysis.
Najafi S; Abedini F; Azimzadeh Jamalkandi S; Shariati P; Ahmadi A; Gholami Fesharaki M
BMC Microbiol; 2021 Nov; 21(1):315. PubMed ID: 34763672
[TBL] [Abstract][Full Text] [Related]
30. Microbiota of Breast Tissue and Its Potential Association with Regional Recurrence of Breast Cancer in Korean Women.
Kim HE; Kim J; Maeng S; Oh B; Hwang KT; Kim BS
J Microbiol Biotechnol; 2021 Dec; 31(12):1643-1655. PubMed ID: 34584037
[TBL] [Abstract][Full Text] [Related]
31. A Procarcinogenic Colon Microbe Promotes Breast Tumorigenesis and Metastatic Progression and Concomitantly Activates Notch and β-Catenin Axes.
Parida S; Wu S; Siddharth S; Wang G; Muniraj N; Nagalingam A; Hum C; Mistriotis P; Hao H; Talbot CC; Konstantopoulos K; Gabrielson KL; Sears CL; Sharma D
Cancer Discov; 2021 May; 11(5):1138-1157. PubMed ID: 33408241
[TBL] [Abstract][Full Text] [Related]
32. Microbiome harbored within tumors: a new chance to revisit our understanding of cancer pathogenesis and treatment.
Zhao K; Hu Y
Signal Transduct Target Ther; 2020 Jul; 5(1):136. PubMed ID: 32728023
[No Abstract] [Full Text] [Related]
33. Cancer-Type-Specific Bacteria: Freeloaders or Partners?
Greathouse KL; Stone JK; Harris CC
Cancer Cell; 2020 Aug; 38(2):158-160. PubMed ID: 32649886
[TBL] [Abstract][Full Text] [Related]
34. Bacterial residents.
Dart A
Nat Rev Cancer; 2020 Aug; 20(8):413. PubMed ID: 32572206
[No Abstract] [Full Text] [Related]
35. Tumors Appear Rife with Bacterial Lodgers.
Cancer Discov; 2020 Aug; 10(8):1085-1086. PubMed ID: 32554395
[TBL] [Abstract][Full Text] [Related]
36. Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy.
Shui L; Yang X; Li J; Yi C; Sun Q; Zhu H
Front Immunol; 2019; 10():2989. PubMed ID: 32010123
[TBL] [Abstract][Full Text] [Related]
37. Deep microbial analysis of multiple placentas shows no evidence for a placental microbiome.
Kuperman AA; Zimmerman A; Hamadia S; Ziv O; Gurevich V; Fichtman B; Gavert N; Straussman R; Rechnitzer H; Barzilay M; Shvalb S; Bornstein J; Ben-Shachar I; Yagel S; Haviv I; Koren O
BJOG; 2020 Jan; 127(2):159-169. PubMed ID: 31376240
[TBL] [Abstract][Full Text] [Related]
38. Human placenta has no microbiome but can contain potential pathogens.
de Goffau MC; Lager S; Sovio U; Gaccioli F; Cook E; Peacock SJ; Parkhill J; Charnock-Jones DS; Smith GCS
Nature; 2019 Aug; 572(7769):329-334. PubMed ID: 31367035
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Integration of Single-Cell Data.
Stuart T; Butler A; Hoffman P; Hafemeister C; Papalexi E; Mauck WM; Hao Y; Stoeckius M; Smibert P; Satija R
Cell; 2019 Jun; 177(7):1888-1902.e21. PubMed ID: 31178118
[TBL] [Abstract][Full Text] [Related]
40. Preexisting Commensal Dysbiosis Is a Host-Intrinsic Regulator of Tissue Inflammation and Tumor Cell Dissemination in Hormone Receptor-Positive Breast Cancer.
Buchta Rosean C; Bostic RR; Ferey JCM; Feng TY; Azar FN; Tung KS; Dozmorov MG; Smirnova E; Bos PD; Rutkowski MR
Cancer Res; 2019 Jul; 79(14):3662-3675. PubMed ID: 31064848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
